Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Recall of GlucoPro Insulin Syringes
Nipro Medical Corporation has issued a nationwide recall of all GlucoPro Insulin Syringes. These recalled syringes may have needles that detach from the syringe. When the needle becomes detached from the syringe during use, it can become stuck in the insulin vial, pushed back into the syringe, or remain in the skin after an injection. No injuries from the recalled syringes have been reported to date. This recall includes all GlucoPro Insulin Syringe product codes and lot numbers with expiration dates before 2011-11 (November 1, 2011), including: Product code JD+01U3008-5C with lot number A08022 Product code JD+01U3013-5C with lot number A08013 or A08017 Product code JD+01U3108-5C with lot number A08013 or A08017 Product code JD+03U3008-5C with lot number C08022 Product code JD+03U3013-5C with lot number C08013 or C08017 Product code JD+03U3108-5C with lot number C08013 or C08017 Product code JD+05U3008-5C with lot number B08022 Product code JD+05U3013-5C with lot number B08013 or B08017 Product code JD+05U3108-5C with lot number B08013 or B08017 Only GlucoPro Insulin Syringes are the subject of the recall. For more information please visit: http://www.fda.gov/Safety/Recalls/ucm198429.htm
Learn More

New Boxed Warning on Older Class of Antipsychotic Drugs
Today's alert relates to a potential increased risk of death when "conventional" antipsychotics are used in older people with dementia. The U.S. Food and Drug Administration announced that it will now require manufacturers of "conventional" antipsychotic drugs, (such as molindone) to make safety-related changes to prescribing information, or labeling, to warn about an increased risk of death associated with the off-label use of these drugs to treat behavioral problems in older people with dementia. For More Information: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm107211.htm
Learn More

Date Published Title Drug Source
2010-01-26 Recall of GlucoPro Insulin Syringes Manufacturer
2008-06-17 New Boxed Warning on Older Class of Antipsychotic Drugs Moban FDA
2009-06-08 Antipsychotics Linked With Sudden Cardiac Death Moban MediGuard CRT
2010-01-20 Endo Discontinues Making Moban (molindone hydrochloride) Moban Manufacturer
2011-02-22 Labeling Change for all Antipsychotic Medications: Warnings Regarding Use During Pregnancy Moban FDA
2007-10-24 Updated label regarding allergic reactions and psychiatric symptoms Modafinil FDA
2008-08-12 Angioedema and ACE inhibitors Moexipril MediGuard CRT
2012-10-30 Paddock Laboratories, Inc. Recalls Single Lot of Moexipril Tablets 7.5mg Moexipril FDA
2011-04-19 FDA Requires Manufacturers to Conduct Safety Studies for Long-Acting Beta-Agonists (LABAs) Mometasone and Formoterol FDA
2008-03-27 FDA investigating risk of mood changes and suicidal thoughts Montelukast FDA
2009-01-14 Update on FDA Safety Review Montelukast FDA
2009-06-12 Updated Safety Information from FDA Safety Review Montelukast FDA
2009-08-28 Updated Prescribing Information Available Montelukast FDA
2008-06-10 Selected recall of morphine sulfate 60 mg extended release tablets Morphine Manufacturer
2008-06-16 More bottles of ETHEX morphine sulfate recalled Morphine Manufacturer
2008-11-10 Recall on Several Lots of Morphine Sulfate Extended Release and Immediate Release Tablets Morphine Manufacturer
2009-01-29 Recall on All ETHEX Brand Morphine Tablets and Solution Morphine Manufacturer
2009-04-01 FDA Warns Companies to Stop Producing Unapproved Narcotics Morphine FDA
2011-01-11 Reports of Accidental Overdose With Morphine Sulfate Oral Solution 100 mg per 5 mL (20 mg/mL) Morphine FDA
2012-05-01 Mylan Pharmaceuticals Inc. Recalls Several Lots of Morphine Sulfate ER Tablets, 200 mg Morphine FDA
Back to Consumer Med Safety